DG-3173

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDG-3173
Drug Alias NameVeldoreotide,VeldotideSomatoprimDG-3173PTR-3173 +[6] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSomatostatin receptor 4 agonistsSomatostatin receptor 5 agonistsSomatostatin receptor 2 agonists
TargetsSomatostatin receptor 5Somatostatin receptor 4Somatostatin receptor 2
Therapy Area/IndicationsAcromegaly
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAspire Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAspireo Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsAcromegaly

Other Information

ATC CodeN/A
Related LinksN/A